PillsCard
Lining up the pixels…
Loading the latest data0%
PillsCard
Lining up the pixels…
Disse oplysninger er kun til uddannelsesformål. De er ikke beregnet som medicinsk rådgivning. Konsultér altid en kvalificeret sundhedsfaglig person.
Beskrivelse, Dosering, Bivirkninger, Kontraindikationer. Data from EMA, URPL, openFDA and other regulatory sources.
| Ramipril | Lisinopril | |
|---|---|---|
| Aktive stoffer | RAMIPRIL | LISINOPRIL |
| ATC-kode | C09AA05 | C09AA03 |
| Form | — | TABLET |
| Dosering | — | 40 mg/1 |
| Indgivelsesvej | — | ORAL |
| Producent | ANGITA PHARMA INC. | NuCare Pharmaceuticals, Inc. |
Ramipril (INN: RAMIPRIL, ATC C09AA05) and Lisinopril (INN: LISINOPRIL, ATC C09AA03) differ in active substance, indications, and safety profile. The table above summarizes the clinical differences from regulatory documents.
Combination safety depends on mechanisms and your health profile. Use our interactions checker and always consult your doctor or pharmacist before combining medications.
Both drugs are approved when used per label. Safety is patient-specific — the better choice depends on your condition, other medications, allergies, and comorbidities. Consult a healthcare professional for personalized advice.
Disse oplysninger er kun til uddannelsesformål. De er ikke beregnet som medicinsk rådgivning. Konsultér altid en kvalificeret sundhedsfaglig person.